Trial Profile
Phase I Study of KLT in Patients With Solid Tumors Refractory to Standard Therapy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Sep 2014
Price :
$35
*
At a glance
- Drugs Kanglaite (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors KangLaiTe USA
- 25 Sep 2014 New trial record